Mankind Pharma Ltd Q3 FY2024-2025 Results: Summary
Revenue | ₹3,310.76Cr |
Net Profits | ₹380.23Cr |
Net Profit Margins | 11.48% |
Highlights
Revenue:
Mankind Pharma Ltd’s revenue jumped 23.46% since last year same period to ₹3,310.76Cr in the Q3 2024-2025. On a quarterly growth basis, Mankind Pharma Ltd has generated 3.83% jump in its revenue since last 3-months.
Net Profits:
Mankind Pharma Ltd’s net profit fell -16.2% since last year same period to ₹380.23Cr in the Q3 2024-2025. On a quarterly growth basis, Mankind Pharma Ltd has generated -41.81% fall in its net profits since last 3-months.
Net Profit Margins:
Mankind Pharma Ltd’s net profit margin fell -32.13% since last year same period to 11.48% in the Q3 2024-2025. On a quarterly growth basis, Mankind Pharma Ltd has generated -43.96% fall in its net profit margins since last 3-months.
